• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Life Sciences British Columbia

  • Members Area |
  • Contact Us
  • SearchSearch
  • About
    • Board of Directors
    • Management
    • Vision & Mission
    • LSBC Hall of Fame
  • Awards
  • Membership
    • Sponsors
    • Members Directory
    • Members Area
    • Membership Benefits
    • Membership Discounts
    • Members Services
    • Members Map
    • Become a Member
  • Events
    • Calendar
    • Webinars
    • Past Events
      • 2023 Events
      • 2022 Events
      • 2021 Events
      • 2020 Events
      • 2019 Events
      • 2018 Events
  • News
    • All News
    • Member News
    • Industry News
    • LSBC in The News
    • Publications
    • BC Labour Market Study
  • Resources
    • All Resources
    • Grants and Funding
      • Funding Competitions
      • Wage Subsidies
    • Academic Institutions
    • Government
      • Federal
      • Provincial and Municipal
    • Association Partners
    • Programs
    • Volunteering
  • Jobs
    • Job Board
    • Post a Job
    • Career Events
  • Contact Us
  • Login
Search
Generic filters
Home » Member News

Member News

  • Member News
  • Industry News
  • LSBC in The News
Member News

LifeLabs Launches Signatera, Offering Canadians an Innovative and Personalized Approach to Managing Cancer

February 1, 2023 – LifeLabs Medical Laboratory Services

TORONTO, ON — LifeLabs is pleased to share the launch of SignateraTM, a highly sensitive, personalized molecular residual disease assay (MRD) test developed by Natera for treatment monitoring and molecular residual disease… Read More

Member News

Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential Psychedelic-Assisted Therapy Training using Psilocybe Cubensis Tea

February 1, 2023 – Numinus Wellness Inc.

Clinical trial will be the first to test whole Psilocybe mushrooms for safety and efficacy in a clinical setting; study is expected to provide important data to support increased access to… Read More

Member News

Ondine’s Nasal Photodisinfection Therapy (APDT) Improves Short-Term and Long-Term Immune Response While Significantly Reducing SARS-CoV-2 Infectivity

January 31, 2023 – Ondine Biomedical Inc.

The first randomized, placebo-controlled, single-blind clinical study of Steriwave™ nasal photodisinfection in 75 predominantly vaccinated COVID-19 patients has been published. VANCOUVER, BC — (BUSINESS WIRE) — The study, published in… Read More

Member News

adMare BioInnovations Launches the adMare Tx Accelerator to Support Growth of Promising Early-stage Therapeutics Ventures Across Canada

January 30, 2023 – adMare BioInnovations

VANCOUVER, BC, MONTREAL, QC, and TORONTO, ON — adMare BioInnovations is pleased to announce the launch of the adMare Tx Accelerator that will support the most promising ventures across Canada… Read More

Member News

Kite and Arcellx Close Agreement to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma

January 30, 2023 – Gilead Sciences Inc.

SANTA MONICA & REDWOOD CITY, CA — (BUSINESS WIRE) — Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX), today announced the closing of the companies’ previously announced global strategic… Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 274
  • →

Primary Sidebar

  • Category:

  • Sector:

  • Archives:

© 2023 Life Sciences BC  |  Privacy Policy

  • Current Jobs
  • Event Calendar
  • All News
  • Member Directory
    Connect with us
  • LinkedIn
  • Twitter
  • Facebook
  • Instagram
Contact Us